Sector Chart BriaCell Therapeutics Corp.

Stocks

BCT

CA1079303071

Biotechnology & Medical Research

Market Closed - Toronto S.E. 03:59:29 2026-09-25 pm EDT			5-day change	1st Jan Change
6.040 ^CAD	+0.33%		+2.20%	-38.37%

Sep. 14	BriaCell Therapeutics Corp Receives Seventh Consecutive Positive DSMB Recommendation For Pivotal Phase 3 Bria-ABC Study Of Bria-IMT Plus Immune Checkpoint Inhibitor	CI
Sep. 11	Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
BRIACELL THERAPEUTICS CORP.	37.17M	-	-	-	-	-
WUXI APPTEC CO., LTD.	72.26B
ARGENX SE	60.24B
WUXI BIOLOGICS (CAYMAN) INC.	27.73B
INSMED INCORPORATED	25.74B					-
BIONTECH SE	24.75B					-